Symptomology
Symptomology & Clinical Approach
Symptom-based approach to diagnosis and management
Respiratory
History Taking
- •Onset: Sudden (PE, Pneumothorax) vs Gradual (CHF, Pneumonia)
- •Triggers: Exertion, lying flat (Orthopnea), allergen exposure
- •Associated: Chest pain, fever, cough, hemoptysis, leg swelling
- •History: COPD/Asthma, Cardiac disease, DVT risk factors
Differential Diagnosis
Investigations
- •Bedside: SpO2, Vitals, Lung ultrasound
- •Labs: CBC, BMP, BNP (Heart failure), D-dimer (PE rule out), Troponin
- •Imaging: CXR (Pneumonia, edema, PTX), CT PE (if high suspicion)
- •Other: ECG (Ischemia, arrhythmia)
Management
- 1.1. ABCs: Airway patency? Breathing effort? Circulation?
- 2.2. Oxygen: Nasal cannula → Venturi/Non-rebreather → HFNC → BiPAP → Intubation
- 3.3. Wheezing: Albuterol + Ipratropium nebs, Steroids (Prednisone 40mg)
- 4.4. Crackles/Edema: Furosemide 40mg IV (or 2x home dose), Nitrates if HTN
- 5.5. Infection: Antibiotics (Ceftriaxone + Azithro) if pneumonia suspected
Monitoring
Oxygen saturation (Keep >90-92%, >88% in COPD) • Respiratory rate and work of breathing (Accessory muscle use) • Mental status (Hypercapnia check) • Blood pressure (Shock index)
History Taking
- •Productive vs Dry
- •Timing: Nocturnal (Asthma, GERD), Post-prandial (GERD)
- •Triggers: Cold air, exercise, scents
- •Meds: ACE inhibitors?
- •Red flags: Hemoptysis, weight loss, smoking history
Differential Diagnosis
Investigations
- •CXR (Rule out cancer, TB, ILD)
- •Spirometry (PFTs) with bronchodilator response
- •Trial of therapy (PPI for GERD, Nasal steroids for UACS)
- •CT Chest if CXR normal but red flags present
Management
- 1.1. Stop ACE inhibitor (switch to ARB)
- 2.2. UACS: Intranasal steroid (Fluticasone) + Antihistamine
- 3.3. Asthma: Inhaled Corticosteroid (ICS) + LABA
- 4.4. GERD: PPI (Omeprazole 40mg daily) + Lifestyle changes
- 5.5. Smoking cessation
Monitoring
Response to empiric therapy (allow 2-4 weeks) • New symptoms (Hemoptysis)
Respiratory / Chest
History Taking
- •Amount: Streaking vs Massive (>600mL/24h or >100mL/hr = Life-threatening)
- •True hemoptysis (Cough) vs Hematemesis (Vomit) vs Epistaxis (Nose)
- •Associated: Weight loss/Night sweats (TB, Cancer), Dyspnea (PE), Pleuritic pain
- •Risk factors: Smoking, TB exposure, Anticoagulation, Prior PE/DVT
- •History: COPD, Bronchiectasis, Prior cancer
Differential Diagnosis
Investigations
- •CXR: Mass, Infiltrate, Cavitary lesion
- •CT Chest (With contrast): Mass, PE, Bronchiectasis, AVM
- •Sputum: AFB (TB), Cytology (Cancer), Culture
- •Labs: CBC, Coagulation, BMP, UA (Goodpasture's - Pulmonary-renal syndrome)
- •Bronchoscopy: Localize bleeding source, Biopsy mass
- •Consider: Anti-GBM Ab, ANCA, CT Angiography
Management
- 1.1. Massive hemoptysis: Position bleeding side DOWN, Intubation (Large ETT), ICU
- 2.2. Stabilize: IV access, Type and cross, Correct coagulopathy (Reverse anticoagulation)
- 3.3. Bronchoscopy: Localize and potentially control bleeding (Cold saline lavage, Epinephrine, Balloon tamponade)
- 4.4. Bronchial artery embolization: First-line for massive hemoptysis (IR consult)
- 5.5. Treat underlying: Anti-TB therapy, Cancer staging, Antibiotics for infection
Monitoring
Airway patency • Volume of hemoptysis • Hemodynamic stability • Oxygen saturation
History Taking
- •Onset: Acute (Anaphylaxis, Foreign body, Epiglottitis) vs Chronic (Tumor, Subglottic stenosis)
- •Phase: Inspiratory (Supraglottic/Glottic) vs Biphasic (Subglottic) vs Expiratory (Lower airway)
- •Associated: Drooling (Epiglottitis), Voice change (Laryngeal), Recent intubation (Subglottic stenosis)
- •History: Allergies (Anaphylaxis), Surgery/Intubation, Smoking, Radiation
Differential Diagnosis
Investigations
- •Direct visualization: Flexible nasolaryngoscopy (Gold standard)
- •CT Neck with contrast: Abscess, Mass
- •Lateral neck X-ray: Thumbprint sign (Epiglottitis), Retropharyngeal widening
- •Tryptase level: If anaphylaxis (Elevated)
Management
- 1.1. Anaphylaxis: IM Epinephrine 0.3-0.5mg STAT, Airway management, IV fluids
- 2.2. Angioedema (ACE-I): Stop ACE-I permanently, Epinephrine if severe, Consider icatibant for hereditary
- 3.3. Epiglottitis: SECURE AIRWAY first (OR/Anesthesia), IV antibiotics (Ceftriaxone + Vancomycin)
- 4.4. Foreign body: Rigid bronchoscopy/Laryngoscopy for removal
- 5.5. Abscess: CT-guided drainage or Surgical I&D + Antibiotics
Monitoring
Airway patency (Prepare for emergent airway) • Oxygen saturation • Work of breathing
Neurological
History Taking
- •Description: Generalized (Loss of consciousness, Tonic-clonic) vs Focal (Aware, Motor/Sensory)
- •Prodrome: Aura (Visual, Olfactory, Déjà vu)
- •Post-ictal: Confusion, Todd's paralysis (Focal weakness after seizure)
- •Triggers: Sleep deprivation, Alcohol withdrawal, Flashing lights
- •Red flags: Fever (Meningitis), Headache (ICH, Tumor), Trauma, Pregnancy (Eclampsia)
Differential Diagnosis
Investigations
- •Labs: Glucose, Sodium, Calcium, Magnesium, Toxicology screen, Prolactin (elevated post-ictal)
- •CT Head non-contrast (STAT if first seizure or focal deficit)
- •MRI Brain (Better for structural lesions)
- •EEG (After acute phase, looking for epileptiform activity)
- •LP if fever/meningismus
Management
- 1.1. Acute: ABCs, Protect airway, Turn on side, Do NOT restrain
- 2.2. Status Epilepticus (>5min): Benzodiazepines (Lorazepam 4mg IV or Midazolam 10mg IM)
- 3.3. Treat underlying cause (D50 for hypoglycemia, 3% Saline for hyponatremia)
- 4.4. Anti-epileptics: Usually NOT started after single unprovoked seizure (30% recurrence)
- 5.5. Start AED if: 2+ seizures, EEG abnormality, or structural lesion (Levetiracetam 500mg BID)
Monitoring
Recurrent seizures • Level of consciousness • Driving restrictions (varies by jurisdiction)
History Taking
- •Distribution: Unilateral (Stroke, Bell's palsy) vs Bilateral, Proximal vs Distal
- •Onset: Sudden (Stroke) vs Progressive (GBS, Myasthenia)
- •Associated: Numbness (CNS), Diplopia (Myasthenia, Stroke), Dysphagia
- •Pattern: Ascending (GBS), Descending (Botulism)
- •Timing: Worse with activity (Myasthenia), Worse in morning (Polymyalgia)
Differential Diagnosis
Investigations
- •Urgent: CT/MRI Brain/Spine if CNS suspected
- •Labs: CK (Rhabdomyolysis), TSH, Potassium, ESR/CRP
- •EMG/NCS: Differentiate neuropathy vs myopathy vs NMJ
- •Lumbar Puncture: GBS (Elevated protein, normal cells)
- •Acetylcholine receptor antibodies (Myasthenia)
Management
- 1.1. Stroke: Thrombolytics (tPA) if <4.5h, Thrombectomy if large vessel
- 2.2. GBS: IVIG or Plasmapheresis, ICU monitoring (respiratory failure risk)
- 3.3. Myasthenia: Pyridostigmine, Steroids, IVIG/PLEX for crisis
- 4.4. Spinal Cord Compression: Urgent MRI + Neurosurgery consult, Dexamethasone 10mg IV
- 5.5. Correct electrolytes (Potassium, Magnesium)
Monitoring
Respiratory function (NIF/FVC in GBS) • Progression of weakness • Bulbar symptoms (Dysphagia, Aspiration risk)
History Taking
- •Distribution: Glove-and-stocking (Peripheral neuropathy), Dermatomal (Radiculopathy), Hemibody (Stroke)
- •Onset: Acute (Stroke, GBS) vs Chronic (DM neuropathy, B12 def)
- •Associated: Weakness, Pain (Radiculopathy), Balance issues
- •Risk factors: Diabetes, Alcohol, B12 deficiency
- •Positional? Worse at night? (Carpal tunnel)
Differential Diagnosis
Investigations
- •If acute/central: MRI Brain/Spine
- •If chronic/peripheral: EMG/NCS, B12, TSH, HbA1c, RPR (Syphilis)
- •Consider: ANA (Vasculitis), Lyme serology, Heavy metals
- •Phalen's/Tinel's test (Carpal tunnel)
- •Straight leg raise (Radiculopathy)
Management
- 1.1. Treat underlying cause (B12 supplementation, Glucose control)
- 2.2. Neuropathic pain: Gabapentin 300-900mg TID or Duloxetine 60mg daily
- 3.3. Carpal tunnel: Wrist splint at night, Steroid injection, Surgery if severe
- 4.4. Radiculopathy: NSAIDs, PT, Epidural steroid injection
- 5.5. MS: Neurology referral for disease-modifying therapy
Monitoring
Progression • Development of weakness • Falls risk
History Taking
- •Onset: Acute (Delirium) vs Chronic (Dementia)
- •Fluctuating? (Delirium characteristic)
- •Associated: Fever (Infection), Headache (Meningitis, ICH), Focal deficits (Stroke)
- •Medications: New meds, Anticholinergics, Opioids, Benzos
- •Baseline cognition?
Differential Diagnosis
Investigations
- •Vitals: Check glucose immediately (finger stick)
- •Labs: CBC, CMP (Na, Ca, BUN/Cr, Glucose), UA, Ammonia (if liver disease)
- •Imaging: CT Head (Stroke, bleed, Mass)
- •Toxicology: Urine drug screen, Alcohol level
- •Consider: Lumbar puncture (if fever/meningismus), Thiamine level (Wernicke's)
Management
- 1.1. Treat underlying cause (Antibiotics, Correct electrolytes, Stop offending drugs)
- 2.2. Supportive: Reorientation, Avoid restraints, Normalize sleep-wake cycle
- 3.3. Wernicke's encephalopathy: Thiamine 500mg IV TID x3d (BEFORE glucose)
- 4.4. Agitation: Minimize sedation (Haloperidol 0.5-2mg if needed, NOT in Parkinson's)
- 5.5. Avoid anticholinergics (Diphenhydramine) - worsens delirium
Monitoring
CAM-ICU (Confusion Assessment Method) • Safety (Fall risk, Wandering) • Agitation level
ENT / Neuro
History Taking
- •Unilateral vs Bilateral (Unilateral is red flag for acoustic neuroma)
- •Pulsatile vs Non-pulsatile (Pulsatile = Vascular etiology)
- •Associated: Hearing loss, vertigo (Meniere's), fullness
- •Meds: Aspirin, NSAIDs, Loop diuretics, Aminoglycosides
Differential Diagnosis
Investigations
- •Otoscopy: Cerumen, fluid, TM perforation, reddish mass (Glomus)
- •Audiometry: Asymmetric hearing loss?
- •MRI IAC (Internal Auditory Canal): If unilateral + hearing loss
- •CT Angio / MRA: If pulsatile
Management
- 1.1. Treat underlying: Remove wax, stop ototoxic meds
- 2.2. Hearing aids (masks tinnitus)
- 3.3. CBT / Sound therapy (White noise machine)
- 4.4. Treat anxiety/depression
- 5.5. Vascular causes: Refer to Vascular Surgery/ENT
Monitoring
Progression of hearing loss • Development of vertigo or focal neuro deficits
History Taking
- •True vertigo (room spinning) vs Lightheadedness vs Disequilibrium
- •Timing: Seconds (BPPV), Minutes-Hours (Meniere's), Days (Vestibular Neuritis)
- •Triggers: Head movement (BPPV), Hearing loss/tinnitus (Meniere's)
- •Neuro symptoms: Diplopia, dysarthria, ataxia (Central cause - STROKE)
Differential Diagnosis
Investigations
- •Dix-Hallpike Maneuver (BPPV diagnosis)
- •HINTS Exam (Head Impulse, Nystagmus, Test of Skew) - If abnormal → MRI
- •Audiogram (Hearing loss in Meniere's)
- •MRI Brain (If central cause suspected)
Management
- 1.1. BPPV: Epley Maneuver (Canalith repositioning)
- 2.2. Vestibular Neuritis: Meclizine 25mg TID, Valium (short term)
- 3.3. Meniere's: Low salt diet, Diuretics, Betahistine
- 4.4. Central causes: Urgent MRI + Neuro consult
- 5.5. Avoid vestibular suppressants >3 days (delays compensation)
Monitoring
Focal neurologic signs • Recurrence pattern
History Taking
- •Fever? (Bacterial vs Viral)
- •Difficulty swallowing/Drooling (Peritonsillar abscess, Epiglottitis)
- •Exposure: Sick contacts, Sexual history (GC/Chlamydia)
- •Rash: Scarlet fever (Strep), EBV (Ampicillin rash)
Differential Diagnosis
Investigations
- •Rapid Strep Test + Throat Culture
- •Monospot / EBV Titers (if splenomegaly, atypical lymphocytes)
- •Soft Tissue Neck X-ray or CT (if abscess suspected)
Management
- 1.1. GAS Pharyngitis: Penicillin V 500mg TID x10d or Amoxicillin
- 2.2. Supportive: NSAIDs, Salt water gargles, Fluids
- 3.3. EBV: Rest, avoid contact sports (Splenic rupture risk x4-6wks)
- 4.4. Peritonsillar Abscess: I&D + Augmentin + ENT consult
- 5.5. Epiglottitis: SECURE AIRWAY (ENT/Anesthesia), Antibiotics
Monitoring
Airway patency (Stridor, Drooling) • Development of rheumatic fever (untreated Strep)
Musculoskeletal
History Taking
- •Acute (<6wks) vs Chronic (>6wks)
- •Trauma? (Fracture, Ligament tear, Meniscus)
- •Joint involved: Knee, Hip, Shoulder (common), 1st MTP (Gout)
- •Associated: Fever (Septic arthritis), Skin changes, Morning stiffness
- •Risk factors: Immunosuppression, IVDU, Recent procedure
Differential Diagnosis
Investigations
- •Arthrocentesis (MANDATORY if acute + effusion): Send for:
- • - Cell count/diff (>50k WBC = Septic, >2k with crystals = Gout/Pseudogout)
- • - Gram stain & Culture
- • - Crystal analysis (Polarized microscopy)
- •Labs: CBC, ESR/CRP, Uric acid, Blood cultures (if fever)
- •Imaging: X-ray (Fracture, OA), MRI (Soft tissue)
Management
- 1.1. Septic Arthritis: URGENT Orthopedic consult + IV Antibiotics (Vanc + Ceftriaxone)
- 2.2. Gout: NSAIDs (Indomethacin 50mg TID) or Colchicine 1.2mg then 0.6mg 1h later
- 3.3. Pseudogout: NSAIDs, Colchicine, or Intra-articular steroid
- 4.4. OA: Acetaminophen, NSAIDs, Physical therapy, Weight loss
- 5.5. Rest, Ice, Elevation, Immobilization PRN
Monitoring
Response to antibiotics (if septic) • Joint function • Recurrence
History Taking
- •Red Flags: Age >50 or <20, Trauma, Cancer history, Fever, Neurologic deficit, Saddle anesthesia, Bowel/Bladder dysfunction
- •Radiculopathy? Pain down leg (Sciatica = L5/S1)
- •Morning stiffness >30min improves with activity (Inflammatory - Ankylosing Spondylitis)
- •Exacerbation: Bending, Lifting, Prolonged sitting
Differential Diagnosis
Investigations
- •Imaging NOT needed if no red flags and <6 weeks duration
- •If red flags: MRI Lumbar spine (Cauda equina, Abscess, Tumor)
- •X-ray: Fracture, Spondylolisthesis (rarely changes management)
- •Labs: ESR/CRP (Infection/Inflammation), CBC
Management
- 1.1. Reassurance: 90% resolve in 6 weeks
- 2.2. Stay active: Bed rest NOT recommended
- 3.3. NSAIDs: Ibuprofen 600mg TID or Naproxen 500mg BID
- 4.4. Muscle relaxants: Cyclobenzaprine 5-10mg THS (short term <2wks)
- 5.5. Physical Therapy: Core strengthening, Stretching
- 6.6. EMERGENCY: Cauda Equina → Urgent MRI + Neurosurgery consult
Monitoring
Progressive neurologic deficit • Bladder/Bowel function • Pain severity and functional status
History Taking
- •Onset: Acute (Trauma, Dislocation) vs Chronic (Impingement, OA)
- •Location: Anterior (Biceps tendon), Lateral (Rotator cuff), Superior (AC joint)
- •Pain with overhead activities? (Impingement, Rotator cuff)
- •Night pain? (Rotator cuff tear)
- •Limited ROM? Active vs Passive (Frozen shoulder = both limited)
Differential Diagnosis
Investigations
- •Physical Exam: Hawkins-Kennedy (Impingement), Drop arm (RC tear), Apprehension (Instability)
- •X-ray: Dislocation, Fracture, AC separation, Calcific tendinitis
- •MRI: Rotator cuff tear, Labral tear
- •Ultrasound: Dynamic assessment of rotator cuff
Management
- 1.1. Impingement: NSAIDs, Physical therapy (Strengthening), Subacromial steroid injection
- 2.2. Rotator cuff tear: PT first, Surgery if full-thickness + symptoms persist
- 3.3. Frozen shoulder: NSAIDs, PT (Aggressive stretching), Intra-articular steroid
- 4.4. Dislocation: Reduction, Immobilization, Orthopedic follow-up
- 5.5. Avoid provocative activities, Ice
Monitoring
ROM progression • Strength improvement • Response to therapy
Cardiovascular
History Taking
- •Character: Regular (SVT) vs Irregular (AFib), Fluttering vs Pounding
- •Duration: Seconds (PACs/PVCs) vs Sustained (SVT, AFib)
- •Associated: Syncope (VT), Chest pain, Dyspnea
- •Triggers: Caffeine, Stress, Exercise
- •Meds: Beta-agonists, Stimulants, Thyroid replacement
Differential Diagnosis
Investigations
- •12-lead ECG during episode (Gold standard)
- •Holter Monitor (24-48h) or Event Monitor (30 days)
- •Labs: TSH, CBC (Anemia), BMP (Electrolytes), Troponin
- •Echo: If structural disease suspected
Management
- 1.1. Treat underlying (Beta-blocker for Hyperthyroid)
- 2.2. SVT: Vagal maneuvers → Adenosine
- 3.3. AFib: Rate control (Metoprolol) + Anticoagulation (CHADS-VASc)
- 4.4. VT: Cardioversion if unstable, Amiodarone if stable
- 5.5. Reassurance for benign PACs/PVCs
Monitoring
Frequency and triggers • Syncope or pre-syncope
History Taking
- •Prodrome: Lightheaded/Vision change (Vasovagal) vs None (Cardiac)
- •Position: Standing (Orthostatic) vs Exertional (Cardiac - dangerous!)
- •Recovery: Immediate (Vasovagal) vs Prolonged/Confused (Seizure)
- •Triggers: Pain, Fear, Urination/Defecation (Vasovagal)
- •Red Flags: Exertional, No warning, Family hx sudden death, Palpitations
Differential Diagnosis
Investigations
- •ECG: QTc prolongation, Pre-excitation (WPW), Q waves (Prior MI), Epsilon wave (ARVC)
- •Orthostatic Vitals: Drop >20 systolic or >10 diastolic
- •Echo: AS, HOCM
- •Tilt Table Test: Vasovagal confirmation
- •EP Study: If high suspicion of arrhythmia
Management
- 1.1. Vasovagal: Reassurance, Hydration, Compression stockings, Counter-pressure maneuvers
- 2.2. Orthostatic: Discontinue offending meds, Volume expansion, Fludrocortisone
- 3.3. Cardiac: Treat arrhythmia, Pacemaker if bradycardia, ICD if VT risk
- 4.4. AS/HOCM: Cardiology referral ± Surgery
- 5.5. Driving restrictions if cardiac cause (varies by region)
Monitoring
Recurrence (High risk if cardiac cause) • Injury from fall
Vascular / Extremities
History Taking
- •Onset: Sudden (Arterial embolism) vs Gradual (DVT, Cellulitis)
- •Character: Cramping (Claudication, DVT) vs Burning/Aching (Venous), Severe rest pain (Critical limb ischemia)
- •Associated: Swelling (DVT, Cellulitis), Color change (Pale = Arterial, Red/Warm = Venous/Infection), Skin changes
- •Risk factors (DVT): Immobilization, Surgery, Cancer, OCPs, Pregnancy, Prior VTE
- •Risk factors (PAD): Smoking, DM, HTN, Hyperlipidemia
Differential Diagnosis
Investigations
- •DVT: Duplex Ultrasound (Compression US), D-dimer (Only if low Wells score)
- •Arterial: ABI (Ankle-Brachial Index - <0.9 = PAD), CTA/MRA, Doppler US
- •Infection: CBC, CRP, Blood cultures, Imaging if deep infection suspected
- •Compartment syndrome: Compartment pressure measurement (>30mmHg diagnostic)
Management
- 1.1. DVT: Anticoagulation - Rivaroxaban 15mg BID x21d then 20mg daily, or LMWH bridge to Warfarin
- 2.2. Acute Limb Ischemia: EMERGENCY - Heparin bolus, Vascular surgery consult, Embolectomy/Thrombolysis within 6h
- 3.3. Cellulitis: Cephalexin 500mg QID or IV Cefazolin (Severe). Add Vanc if MRSA risk
- 4.4. Necrotizing Fasciitis: SURGICAL EMERGENCY - Debridement, Broad-spectrum antibiotics (Vanc + Zosyn + Clinda)
- 5.5. Compartment Syndrome: EMERGENCY Fasciotomy
Monitoring
Limb perfusion (Pulses, Cap refill, Sensation, Motor) • Compartment pressures if at risk • Signs of PE (if DVT)
Dermatology
History Taking
- •Distribution: Localized vs Generalized, Sun-exposed areas
- •Morphology: Macular, Papular, Vesicular, Pustular, Petechial
- •Associated: Fever (Meningococcemia, SJS), Pruritus (Allergic)
- •Triggers: New medication (Drug rash), Sick contacts, Tick bite
- •Mucosal involvement? (SJS/TEN, Erythema multiforme)
Differential Diagnosis
Investigations
- •Physical: Full body exam, Mucosal membranes, Nikolsky sign (SJS/TEN)
- •Labs: CBC (Eosinophilia in DRESS), CMP, Viral serologies
- •Skin biopsy if unclear diagnosis
- •Consider: Lyme serology, RMSF titers
Management
- 1.1. Drug reaction: STOP offending agent immediately
- 2.2. SJS/TEN: Burn unit admission, Supportive care, IV fluids, Consider IVIG
- 3.3. Urticaria: Antihistamines (Cetirizine 10mg daily), Steroids if severe
- 4.4. Contact dermatitis: Topical steroids (Triamcinolone 0.1%)
- 5.5. Viral exanthem: Supportive care
Monitoring
Progression to mucosal involvement • Systemic symptoms (Fever, Hypotension) • Body surface area involved
History Taking
- •Rash present? (Primary skin disease) vs No rash (Systemic cause)
- •Timing: Worse at night (Scabies, Hodgkin's), After shower (Aquagenic, Polycythemia Vera)
- •Associated: Jaundice (Cholestasis), Uremia, Weight loss
- •New meds: Opioids, Aspirin
- •Family history: Atopy
Differential Diagnosis
Investigations
- •Labs: CBC (Polycythemia), CMP (Renal), LFTs (Cholestasis), TSH
- •Consider: HIV test, Hepatitis panel, Chest X-ray (Lymphoma)
- •Skin scraping: If scabies suspected
- •Biopsy: If unclear
Management
- 1.1. Treat underlying cause (Ursodeoxycholic acid for cholestasis)
- 2.2. Topical: Emollients (Frequent moisturizing), Menthol/Camphor
- 3.3. Oral antihistamines: Hydroxyzine 25-50mg QHS, Cetirizine 10mg daily
- 4.4. Gabapentin 300-900mg for neuropathic itch
- 5.5. UV phototherapy for chronic cases
Monitoring
Development of jaundice • Excoriations/Secondary infection • Sleep disturbance
Hematology
History Taking
- •Onset: Acute (GI bleed, Hemolysis) vs Chronic (Iron def, CKD)
- •Symptoms: Fatigue, Dyspnea on exertion, Lightheadedness, Chest pain (if severe)
- •Bleeding: Melena, Hematochezia, Menorrhagia, Hematuria
- •Diet: Iron intake, B12 source (Vegans at risk)
- •Past: History of anemia, Family history (Thalassemia, Sickle cell)
Differential Diagnosis
Investigations
- •Initial: CBC with differential, Reticulocyte count, Peripheral smear
- •Iron studies: Ferritin (best for iron def), TIBC, Transferrin saturation
- •Hemolysis markers: LDH, Haptoglobin, Indirect bilirubin, Direct Coombs
- •B12/Folate levels, TSH
- •Endoscopy: If iron def without obvious source (occult GI bleed)
Management
- 1.1. Acute severe (Hgb<7, symptomatic): Blood transfusion (1 unit = +1 g/dL Hgb)
- 2.2. Iron deficiency: Oral iron 325mg (65mg elemental) daily on empty stomach + Vitamin C
- 3.3. B12 deficiency: Cyanocobalamin 1000mcg IM weekly x4-8wks, then monthly
- 4.4. Folate deficiency: Folic acid 1-5mg daily
- 5.5. Treat underlying cause (Stop NSAIDs, Treat IBD, etc)
Monitoring
Hemodynamic stability • Response to iron/B12 supplementation • Reticulocyte count (should rise with treatment)
History Taking
- •Location: Petechiae/Purpura (Platelet), Hemarthrosis (Factor def - Hemophilia)
- •Onset: Lifelong (Inherited) vs Recent (Acquired)
- •Pattern: Immediate (Platelet/Vascular) vs Delayed (Factor def)
- •Associated: Gingival bleeding, Epistaxis, Menorrhagia
- •Medications: Anticoagulants, Antiplatelet, NSAIDs, SSRIs
Differential Diagnosis
Investigations
- •CBC with platelet count
- •PT/INR (Extrinsic pathway - Warfarin, Liver disease)
- •PTT (Intrinsic pathway - Heparin, Hemophilia)
- •Fibrinogen, D-dimer (DIC)
- •Peripheral smear: Schistocytes (TTP/HUS)
- •Consider: vWF studies, Factor assays
Management
- 1.1. ITP: Steroids (Prednisone 1mg/kg), IVIG if severe (<20k platelets + bleeding)
- 2.2. TTP: Plasma exchange (URGENT), Rituximab
- 3.3. Hemophilia: Factor replacement (Factor VIII or IX)
- 4.4. Vitamin K deficiency: Vitamin K 10mg IV (INR elevated from Warfarin/Malnutrition)
- 5.5. DIC: Treat underlying cause, Supportive (FFP, Platelets, Cryo)
Monitoring
Active bleeding sites • Hemoglobin trend • Response to treatment
Endocrine
History Taking
- •Urine volume: >3L/day = Polyuria
- •Onset: Acute (DI, DKA) vs Chronic (DM, Primary polydipsia)
- •Nocturia? (DI, DM, CHF)
- •Associated: Weight loss (DM), Hypernatremia (DI), Hypokalemia (Primary aldosteronism)
- •Medications: Diuretics, Lithium (causes Nephrogenic DI)
Differential Diagnosis
Investigations
- •Labs: Glucose, HbA1c, Sodium, Calcium, Potassium, BUN/Cr
- •Urine: Osmolality, Specific gravity (Low in DI)
- •Serum osmolality
- •Water deprivation test: Differentiates DI from primary polydipsia
- •Desmopressin trial: Nephrogenic vs Central DI
- •MRI Pituitary if Central DI suspected
Management
- 1.1. Diabetes Mellitus: Insulin (Type 1) or Oral hypoglycemics (Type 2)
- 2.2. Central DI: Desmopressin (DDAVP) 0.1-0.4mg daily
- 3.3. Nephrogenic DI: Treat cause (Stop Lithium), Thiazide diuretics + Low sodium diet
- 4.4. Primary Polydipsia: Psychiatric evaluation, Fluid restriction
- 5.5. Monitor for dehydration and electrolyte abnormalities
Monitoring
Fluid balance (Intake/Output) • Serum sodium (Risk of hypernatremia) • Weight
History Taking
- •Heat intolerance + Weight loss + Palpitations = Hyperthyroidism
- •Cold intolerance + Weight gain + Fatigue = Hypothyroidism
- •Associated: Tremor, Anxiety (Hyper), Constipation, Dry skin (Hypo)
- •Neck swelling? (Goiter)
- •Eye changes? (Graves' ophthalmopathy)
Differential Diagnosis
Investigations
- •TSH: Low (Hyperthyroid), High (Hypothyroid) - BEST screening test
- •Free T4 and T3
- •Thyroid antibodies: Anti-TPO (Hashimoto's), TSI (Graves')
- •Radioactive iodine uptake scan: High (Graves'), Low (Thyroiditis)
- •Thyroid ultrasound: Nodules
Management
- 1.1. Hyperthyroidism: Beta-blocker (Propranolol 20-40mg TID) for symptoms, Methimazole 15-30mg daily
- 2.2. Graves': Radioactive iodine ablation or Thyroidectomy
- 3.3. Thyroid storm: Propranolol, PTU/Methimazole, Hydrocortisone, Cooling
- 4.4. Hypothyroidism: Levothyroxine 1.6 mcg/kg/day (typically 50-100mcg)
- 5.5. Myxedema coma: ICU, IV Levothyroxine, Hydrocortisone
Monitoring
Symptoms resolution • TSH levels (Check 6-8 weeks after dose change) • Cardiac symptoms (AFib risk in hyperthyroid)
Psychiatric
History Taking
- •Symptoms: Palpitations, Sweating, Trembling, SOB, Chest pain, Nausea, Dizziness
- •Duration: Peak within 10 minutes, Resolve in 30 minutes (Panic attack)
- •Triggers: Specific phobias, Social situations, or Spontaneous
- •Frequency: Recurrent panic = Panic disorder
- •Rule out medical causes first!
Differential Diagnosis
Investigations
- •ECG: Rule out MI, arrhythmia
- •Labs: TSH, Glucose, CBC
- •Consider: D-dimer (PE), Troponin, Tox screen
- •Screening: GAD-7 (Generalized Anxiety Disorder scale)
Management
- 1.1. Acute: Reassurance, Breathing exercises (Not hyperventilation into bag)
- 2.2. Short-term: Benzodiazepines (Lorazepam 0.5-1mg PRN - caution: dependence)
- 3.3. Long-term: SSRIs (Sertraline 50mg daily, Escitalopram 10mg)
- 4.4. Cognitive Behavioral Therapy (CBT) - First line!
- 5.5. Lifestyle: Exercise, Sleep hygiene, Reduce caffeine/alcohol
Monitoring
Frequency of attacks • Functional impairment • Depression screening (High comorbidity)
History Taking
- •Type: Sleep onset (Anxiety) vs Maintenance (Depression, OSA) vs Early morning awakening (Depression)
- •Duration: Acute (<3mo) vs Chronic (>3mo)
- •Sleep hygiene: Screen time, Caffeine, Exercise timing, Bedroom environment
- •Associated: Depression, Anxiety, Chronic pain, Restless legs
- •Snoring/Witnessed apneas? (OSA)
Differential Diagnosis
Investigations
- •Screening: PHQ-9 (Depression), GAD-7 (Anxiety), STOP-BANG (OSA)
- •Sleep diary: 2 weeks
- •Labs: TSH if indicated
- •Polysomnography (Sleep study): If OSA suspected
Management
- 1.1. Sleep Hygiene (First line): Consistent schedule, Dark/cool room, No screens 1h before bed
- 2.2. CBT-I (Cognitive Behavioral Therapy for Insomnia): Stimulus control, Sleep restriction
- 3.3. Melatonin 3-5mg 1h before bed (Safe, no dependence)
- 4.4. Short-term: Zolpidem 5-10mg, Trazodone 25-50mg, Doxepin 3-6mg
- 5.5. Treat underlying: OSA (CPAP), Depression (SSRI), Pain
Monitoring
Sleep quality and duration • Daytime functioning • Mood
History Taking
- •Core symptoms: Depressed mood, Anhedonia (Loss of interest/pleasure) - Need ≥1
- •Duration: >2 weeks, Most days, Most of the day
- •Associated: Sleep changes, Appetite/Weight change, Fatigue, Worthlessness/Guilt, Poor concentration, Psychomotor changes
- •Suicidality: ALWAYS assess (Ideation, Plan, Intent, Means)
- •Psychotic features? (MDD with psychosis)
Differential Diagnosis
Investigations
- •Screening: PHQ-9 (Score >10 = Moderate-severe depression)
- •Labs: TSH, CBC, B12, Vitamin D, CMP
- •Toxicology if substance use suspected
- •Risk assessment: Columbia Suicide Severity Rating Scale (C-SSRS)
Management
- 1.1. Mild-Moderate: Psychotherapy (CBT, IPT) +/- Medication
- 2.2. Moderate-Severe: SSRI (Sertraline 50mg, Escitalopram 10mg, Fluoxetine 20mg) + Therapy
- 3.3. Alternative: SNRI (Venlafaxine, Duloxetine), Bupropion (Good if fatigue/low energy)
- 4.4. Severe/Psychotic: Antidepressant + Antipsychotic, Consider ECT
- 5.5. Safety: Hospitalization if acute suicide risk
- 6.6. Response takes 4-6 weeks, Continue 6-12 months after remission
Monitoring
Suicide risk (Highest in first weeks of treatment) • PHQ-9 scores (Track response) • Side effects of medications • Activation/Mania (If undiagnosed Bipolar)
Ophthalmology
History Taking
- •Unilateral vs Bilateral (Bilateral suggests viral or allergic)
- •Pain: Severe deep pain (Uveitis, Glaucoma) vs Gritty/Foreign body (Conjunctivitis)
- •Vision changes: Blurred (Keratitis, Uveitis, Glaucoma) vs Normal (Conjunctivitis)
- •Discharge: Purulent (Bacterial), Watery (Viral/Allergic), None (Uveitis)
- •Contact lens use? (Keratitis - Pseudomonas!)
- •Photophobia? (Uveitis, Keratitis)
Differential Diagnosis
Investigations
- •Visual acuity (ALWAYS test first)
- •Slit-lamp exam: Cells/Flare (Uveitis), Dendritic ulcer (HSV), Corneal opacity
- •Intraocular pressure: Elevated (>21mmHg) in Glaucoma
- •Fluorescein staining: Corneal abrasion, Dendritic ulcer
- •If uveitis: HLA-B27, RPR, ACE level, CXR, TB testing
Management
- 1.1. Bacterial conjunctivitis: Erythromycin ointment or Fluoroquinolone drops (Moxifloxacin)
- 2.2. Viral conjunctivitis: Supportive, Cold compresses, Artificial tears (Self-limited 1-2wks)
- 3.3. Allergic: Antihistamine/Mast cell stabilizer drops (Olopatadine), Avoid allergens
- 4.4. HSV keratitis: Oral Valacyclovir + Trifluridine drops (NO STEROIDS - worsens!)
- 5.5. Uveitis: Topical steroids + Cycloplegics (Ophthalmology referral)
- 6.6. Acute Angle-Closure Glaucoma: EMERGENCY - Timolol drops, Pilocarpine, Acetazolamide IV → Laser iridotomy
Monitoring
Vision changes • Worsening pain or photophobia • Response to treatment
History Taking
- •Onset: Sudden painless (Retinal artery/vein occlusion, Retinal detachment) vs Painful (Optic neuritis, Glaucoma)
- •Duration: Transient (Amaurosis fugax - TIA) vs Persistent
- •Unilateral vs Bilateral (Bilateral = Stroke, Giant Cell Arteritis)
- •Visual field: Curtain/Veil (Retinal detachment), Central scotoma (Optic neuritis, Macular)
- •Associated: Flashes/Floaters (Retinal detachment), Headache (GCA, Stroke), Eye pain (Optic neuritis)
Differential Diagnosis
Investigations
- •Visual acuity and Visual field testing
- •Fundoscopy: Cherry-red spot (CRAO), Disc edema (Optic neuritis, NAION), Flame hemorrhages (CRVO)
- •ESR/CRP: If GCA suspected (ESR often >50)
- •MRI Brain/Orbits: Optic neuritis (MS), Stroke
- •CT Head: Stroke, Mass lesion
- •Carotid ultrasound: If amaurosis fugax (Embolic source)
Management
- 1.1. CRAO: EMERGENCY - Ocular massage, Lower IOP (Timolol, Anterior chamber paracentesis), tPA within 4.5h
- 2.2. GCA: High-dose steroids IMMEDIATELY (Prednisolone 60-80mg or Methylpred 1g IV) - Prevent bilateral blindness
- 3.3. Retinal Detachment: URGENT Ophthalmology referral for surgical repair
- 4.4. Optic Neuritis: IV Methylprednisolone 1g x3d → Oral taper, MRI for MS evaluation
- 5.5. Amaurosis Fugax: Stroke workup (Carotid US, Echo, MRA), Antiplatelet therapy
Monitoring
Serial visual acuity • Fellow eye involvement (GCA can affect both) • Neurological status
Obstetrics / Gynecology
History Taking
- •Amount: Spotting vs Heavy bleeding (Soaking pads)
- •Pain: Cramping (Threatened/Inevitable abortion), Unilateral (Ectopic pregnancy)
- •LMP: Gestational age estimation
- •Previous: Prior ectopic, Miscarriage history, IVF
- •Risk factors: IUD, PID history, Tubal surgery (Ectopic risk)
Differential Diagnosis
Investigations
- •Beta-hCG: Quantitative (Double q48h in viable pregnancy), Serial levels
- •Transvaginal Ultrasound: Intrauterine pregnancy? Ectopic? Fetal heartbeat?
- •CBC: Hemoglobin (Assess blood loss)
- •Blood type and Rh: RhoGAM if Rh-negative
- •Progesterone: Low level concerning for non-viable pregnancy
Management
- 1.1. Ectopic (Unstable): EMERGENCY surgery (Salpingectomy or Salpingostomy)
- 2.2. Ectopic (Stable, <3.5cm, no FHR): Methotrexate IM
- 3.3. Threatened abortion: Pelvic rest, Follow-up US, Reassurance
- 4.4. Incomplete: Expectant management, Misoprostol, or D&C
- 5.5. RhoGAM 300mcg IM if Rh-negative (Within 72h of bleeding)
Monitoring
Hemodynamic stability • Serial beta-hCG (q48h) • Repeat ultrasound if indeterminate
History Taking
- •Timing: Mid-cycle (Mittelschmerz, Ruptured cyst), Menstrual (Dysmenorrhea, Endometriosis)
- •Location: Unilateral (Ovarian), Bilateral/Central (PID, Uterine)
- •Associated: Fever/Discharge (PID), Amenorrhea (Ectopic), Urinary symptoms
- •Sexual history: STI exposure, New partner
- •LMP: Rule out pregnancy first!
Differential Diagnosis
Investigations
- •Beta-hCG: ALWAYS in reproductive age females
- •UA: UTI, Kidney stone
- •CBC/CRP: Infection, Inflammation
- •Pelvic Ultrasound: Ovarian cyst, Torsion (Absent Doppler flow), Ectopic
- •NAAT: GC/Chlamydia if PID suspected
- •CT Abdomen/Pelvis: If non-gyn pathology suspected
Management
- 1.1. Ovarian Torsion: SURGICAL EMERGENCY - Detorsion ± Oophorectomy
- 2.2. PID: Ceftriaxone 500mg IM + Doxycycline 100mg BID x14d + Metronidazole 500mg BID x14d
- 3.3. Ruptured ovarian cyst: Usually conservative (NSAIDs, Monitor Hgb), Surgery if hemodynamically unstable
- 4.4. Endometriosis: NSAIDs, Hormonal therapy (OCPs, GnRH agonists), Laparoscopy for refractory
- 5.5. Dysmenorrhea: NSAIDs (Start before menses), OCPs, Consider IUD (Mirena)
Monitoring
Hemodynamic stability • Fever curve • Pain progression
History Taking
- •Pattern: Heavy (Menorrhagia), Irregular (Metrorrhagia), Post-menopausal (Cancer until proven otherwise)
- •Duration: >7 days per cycle, >80mL blood loss
- •Associated: Weight changes (Thyroid, PCOS), Hirsutism (PCOS), Easy bruising (Coagulopathy)
- •Medications: Anticoagulants, Hormonal contraceptives
- •Age: Adolescent (Anovulatory), Reproductive (Structural), Post-menopausal (Malignancy)
Differential Diagnosis
Investigations
- •Beta-hCG: Rule out pregnancy
- •CBC: Assess for anemia
- •TSH, Prolactin: Endocrine causes
- •Coagulation: PT/INR, PTT, vWF (If adolescent or heavy since menarche)
- •Pelvic Ultrasound: Fibroids, Polyps, Endometrial thickness
- •Endometrial biopsy: If >45yo, Post-menopausal, or risk factors for endometrial cancer
- •Saline infusion sonography or Hysteroscopy: Intracavitary lesions
Management
- 1.1. Acute heavy bleeding: IV Estrogen (Premarin), Tranexamic acid 1g TID, D&C if unstable
- 2.2. Hormonal: Combined OCPs, Progestin-only pills, Mirena IUD (First-line for chronic)
- 3.3. Fibroids: GnRH agonists (Pre-surgical shrinkage), Myomectomy, UAE, Hysterectomy
- 4.4. Polyps: Hysteroscopic polypectomy
- 5.5. Iron supplementation for anemia (Ferrous sulfate 325mg daily)
Monitoring
Hemoglobin levels • Endometrial thickness • Response to hormonal therapy
Pediatric
History Taking
- •Temperature: ≥38°C (100.4°F) rectal = Fever
- •Age matters: <28 days (Highest risk), 29-60 days, 61-90 days
- •Birth history: Premature, NICU stay, Maternal GBS status
- •Associated: Irritability, Lethargy, Poor feeding, Rash
- •Immunization status, Sick contacts
Differential Diagnosis
Investigations
- •Full sepsis workup for <28 days: CBC, Blood culture, UA/Urine culture, CSF (LP), CXR if respiratory symptoms
- •29-60 days: Rochester/Philadelphia/Boston criteria to guide workup
- •Inflammatory markers: CRP, Procalcitonin (Better for bacterial)
- •Viral panel: RSV, Influenza, Enterovirus
- •HSV PCR: If vesicles, seizures, LFT abnormalities, or ill-appearing neonate
Management
- 1.1. <28 days: Admit, IV Ampicillin + Gentamicin (or Cefotaxime) pending cultures
- 2.2. Add Acyclovir if HSV suspected (10mg/kg IV q8h)
- 3.3. 29-60 days (Well-appearing): Risk stratify - Low risk may be observed with close follow-up
- 4.4. 29-60 days (Ill-appearing): Admit, IV antibiotics
- 5.5. UTI: Cephalexin (Outpatient) or Ceftriaxone (Inpatient), VCUG after first febrile UTI <2yo
Monitoring
Clinical appearance (Well vs Ill-appearing) • Feeding tolerance • Temperature trend
History Taking
- •Age: <2 years (Bronchiolitis), >2 years (Asthma more likely)
- •First episode vs Recurrent (≥3 episodes = likely asthma)
- •URI prodrome? (Bronchiolitis typically follows URI)
- •Triggers: Cold air, Exercise, Allergens, URI
- •Family history: Atopy, Asthma, Eczema
- •Sudden onset without URI? (Foreign body aspiration!)
Differential Diagnosis
Investigations
- •Clinical diagnosis usually sufficient
- •SpO2: Guide need for supplemental oxygen
- •CXR: If atypical presentation, First wheeze, Unilateral (Foreign body - air trapping)
- •RSV/Viral testing: For isolation purposes (Not to guide treatment)
- •Spirometry: In older children (>5yo) for asthma diagnosis
Management
- 1.1. Bronchiolitis: Supportive ONLY - Suctioning, Oxygen if SpO2 <90%, Hydration. NO albuterol, NO steroids
- 2.2. Asthma (Acute): Albuterol MDI (4-8 puffs) or Nebulizer, Oral prednisolone 1-2mg/kg (max 60mg)
- 3.3. Asthma (Severe): Continuous nebulized albuterol, IV Magnesium sulfate 25-50mg/kg
- 4.4. Foreign Body: Rigid bronchoscopy for removal
- 5.5. Asthma (Chronic): Step-up therapy - ICS (Fluticasone), Add LABA if uncontrolled
Monitoring
Respiratory rate and effort (Retractions, Grunting, Nasal flaring) • Oxygen saturation • Feeding tolerance (Cannot feed = severe) • Apnea (Especially in premature infants with bronchiolitis)
History Taking
- •Rash timing: With fever (Viral exanthem) vs After fever breaks (Roseola)
- •Morphology: Vesicular (Varicella, Hand-Foot-Mouth), Maculopapular (Measles), Petechial (Meningococcemia!)
- •Distribution: Starts face then spreads (Measles), Palms/Soles (RMSF, Hand-Foot-Mouth, Syphilis)
- •Immunization status (Measles, Varicella)
- •Ill contacts, Travel history
Differential Diagnosis
Investigations
- •Clinical diagnosis for most viral exanthems
- •Blood culture + CBC: If meningococcemia suspected (Do NOT delay antibiotics!)
- •Throat culture/Rapid strep: Scarlet fever
- •ESR/CRP, Echo: Kawasaki disease
- •UA: HSP (Hematuria/Proteinuria)
- •Parvovirus B19 IgM: If Fifth disease in pregnant contact
Management
- 1.1. Most viral exanthems: Supportive care, Antipyretics
- 2.2. Meningococcemia: EMERGENCY - IV Ceftriaxone immediately, ICU, Prophylaxis for contacts (Rifampin/Cipro)
- 3.3. Kawasaki: IVIG 2g/kg + High-dose Aspirin → Low-dose Aspirin (Prevent coronary aneurysms)
- 4.4. Scarlet Fever: Penicillin V or Amoxicillin x10 days
- 5.5. Varicella: Acyclovir if immunocompromised or >12yo, Supportive for healthy children
Monitoring
Petechial progression (Meningococcemia can progress rapidly) • Mucosal involvement (Kawasaki, SJS) • Renal function (HSP)
Renal / Electrolytes
History Taking
- •Urine output: <0.5 mL/kg/hr = Oliguria, <100 mL/day = Anuria
- •Recent: Medications (NSAIDs, ACE-I, Aminoglycosides, Contrast), Surgery, Hypotension
- •Volume status: Vomiting, Diarrhea, Bleeding (Prerenal)
- •Urinary symptoms: Difficulty voiding (Obstruction - BPH, Stone)
- •History: CKD, DM, HTN, Heart failure, Liver disease
Differential Diagnosis
Investigations
- •UA with microscopy: Muddy brown casts (ATN), WBC casts (AIN), RBC casts (GN), Eosinophils (AIN)
- •BMP: Creatinine trend, BUN/Cr ratio (>20:1 = Prerenal)
- •FENa: <1% (Prerenal), >2% (ATN), FEUrea if on diuretics
- •Renal ultrasound: Hydronephrosis (Obstruction), Kidney size
- •Consider: CK (Rhabdomyolysis), Complement levels (GN), ANCA/Anti-GBM
- •Bladder scan: Post-void residual (Retention)
Management
- 1.1. Prerenal: IV fluid resuscitation (NS or LR), Treat underlying cause, Stop nephrotoxins
- 2.2. Obstruction: Foley catheter (Urinary retention), Nephrostomy/Stent (Ureteral)
- 3.3. ATN: Supportive, Avoid further nephrotoxins, Adjust medication doses
- 4.4. Rhabdomyolysis: Aggressive IV NS (200-300mL/hr target UO 200-300mL/hr)
- 5.5. Hyperkalemia: Calcium gluconate → Insulin/Glucose → Kayexalate → Dialysis if refractory
- 6.6. Dialysis indications (AEIOU): Acidosis, Electrolytes (K+), Ingestion (Toxins), Overload, Uremia (Pericarditis, Encephalopathy)
Monitoring
Strict I&O, Daily weights • BMP (Potassium! - Hyperkalemia risk) • Volume status assessment • Urine output trend
History Taking
- •Severity: Mild (130-135), Moderate (125-130), Severe (<125)
- •Symptoms: Asymptomatic (Chronic) vs Headache, Nausea, Confusion, Seizures (Acute/Severe)
- •Volume status: Edema (CHF, Cirrhosis, Nephrotic), Dry (Vomiting, Diarrhea, Diuretics), Euvolemic (SIADH)
- •Medications: Thiazides, SSRIs, Carbamazepine, Desmopressin
- •Medical history: CHF, Cirrhosis, CKD, Hypothyroid, Adrenal insufficiency
Differential Diagnosis
Investigations
- •Serum osmolality: Low (<280) = True hyponatremia
- •Urine osmolality: >100 (Impaired water excretion = SIADH, Volume depletion) vs <100 (Polydipsia)
- •Urine sodium: <20 (Hypovolemic, Edematous states) vs >40 (SIADH, Diuretics, Renal salt wasting)
- •TSH, Cortisol: Rule out hypothyroid and adrenal insufficiency
- •BMP, LFTs, BNP: Assess for CHF, Cirrhosis
Management
- 1.1. Severe/Symptomatic (Seizures): 3% Hypertonic saline 100-150mL bolus over 10-20min, Repeat x2 if needed
- 2.2. SIADH: Fluid restriction (1-1.5L/day), Salt tabs, Tolvaptan (if refractory)
- 3.3. Hypovolemic: NS (0.9%) fluid resuscitation
- 4.4. Hypervolemic: Fluid/Salt restriction, Loop diuretics
- 5.5. CRITICAL: If Na corrects >10-12 mEq in 24h → Give D5W or DDAVP to slow correction (Prevent osmotic demyelination syndrome)
Monitoring
Na correction rate: <10-12 mEq/L in 24h (Risk of osmotic demyelination if too fast!) • Neurologic status (Seizures, AMS) • Strict I&O • Check Na q2-4h during active correction
GI / GU
History Taking
- •Timing: Post-prandial (Obstruction, Gastroparesis), Morning (Pregnancy, ICP)
- •Content: Bilious (Small bowel), Feculent (Distal obstruction), Blood (GI bleed)
- •Associated: Headache (Migraine, Meningitis), Abdominal pain, Diarrhea
- •Meds: Opioids, Chemotherapy, Antibiotics
Differential Diagnosis
Investigations
- •Labs: BMP (Electrolytes), Glucose, Lipase, Beta-hCG, UA
- •Imaging: Abdominal X-ray (Obstruction), CT if surgical abdomen suspected
- •ECG: Rule out MI
Management
- 1.1. Rehydration: PO (if tolerating) or IV fluids
- 2.2. Antiemetics: Ondansetron 4-8mg (Serotonin blocker), Metoclopramide 10mg (Prokinetic), Promethazine 12.5-25mg
- 3.3. Treat underlying cause
- 4.4. NPO if obstruction/ileus
- 5.5. NG tube if severe obstruction
Monitoring
Hydration status (Urine output, Mucous membranes) • Electrolyte abnormalities
History Taking
- •Location: External (Vulvovaginitis, HSV) vs Internal (UTI)
- •Frequency/Urgency? (Cystitis)
- •Hematuria? (Hemorrhagic cystitis, Stones)
- •Discharge? (STI: GC, Chlamydia, Trich)
- •Sexual history, Contraception
Differential Diagnosis
Investigations
- •UA with Micro: Leukocyte esterase, Nitrites, WBCs, Bacteria
- •Urine Culture (if recurrent, complicated, or pyelonephritis)
- •NAAT (GC/Chlamydia) if STI suspected
- •CT Urogram if stones suspected
Management
- 1.1. Uncomplicated Cystitis: Nitrofurantoin 100mg BID x5d or Bactrim DS BID x3d
- 2.2. Pyelonephritis: Cipro 500mg BID x7d (outpatient) or Ceftriaxone 1g IV (inpatient)
- 3.3. STI: Ceftriaxone 500mg IM + Doxycycline 100mg BID x7d
- 4.4. Phenazopyridine (Pyridium) for symptom relief (caution: turns urine orange)
- 5.5. Hydration
Monitoring
Fever development (Pyelonephritis) • Symptom resolution on treatment
General
History Taking
- •Duration (>6mo = Chronic Fatigue Syndrome possibility)
- •Sleep quality (Sleep apnea?)
- •Mood (Depression/Anxiety)
- •Weight change, Cold intolerance (Thyroid)
- •Exertional dyspnea (Anemia, Heart failure)
Differential Diagnosis
Investigations
- •Initial: CBC, CMP, TSH, Ferritin
- •Secondary: B12, Folate, HIV, Hepatitis panel, Cortisol
- •Screening: PHQ-9 (Depression), STOP-BANG (Sleep apnea)
Management
- 1.1. Treat specific cause (Iron for anemia, CPAP for OSA)
- 2.2. Sleep hygiene optimization
- 3.3. Graded Exercise Therapy
- 4.4. Antidepressants if depression component
- 5.5. De-prescribe sedating medications
Monitoring
Functional status impact • Weight changes
History Taking
- •Amount and timeframe (>5% in 6mo = Significant)
- •Appetite: Increased (Hyperthyroid, DM) vs Decreased (Cancer, Depression)
- •Associated: Night sweats (TB, Lymphoma), Diarrhea (Malabsorption), Polyuria (DM)
- •Symptoms: Dysphagia, Abdominal pain, Change in bowel habits
- •Social: Food insecurity, Depression, Dementia
Differential Diagnosis
Investigations
- •Labs: CBC, CMP, TSH, HbA1c, HIV, ESR/CRP
- •Stool: Fecal occult blood, Calprotectin (IBD), Fat (Malabsorption)
- •Imaging: CT Chest/Abdomen/Pelvis (Malignancy search)
- •Endoscopy: If GI symptoms (EGD/Colonoscopy)
- •Age-appropriate cancer screening
Management
- 1.1. Treat underlying cause
- 2.2. Nutritional support: High-calorie diet, Nutritional supplements
- 3.3. Appetite stimulants if appropriate (Megestrol, Mirtazapine)
- 4.4. Address social determinants (Food access, Home support)
- 5.5. Oncology/GI referral if indicated
Monitoring
Serial weights • Nutritional status (Albumin, Prealbumin) • Development of new symptoms
History Taking
- •Onset: Sudden (PE, MI, Aortic Dissection) vs Gradual
- •Character: Pressure/Squeezing (ACS), Tearing (Dissection), Sharp/Pleuritic (PE, Pericarditis)
- •Radiation: Jaw/Arm (ACS), Back (Dissection, Pancreatitis)
- •Exertional? Relieved by rest/NTG? (Stable Angina)
- •Risk Factors: Smoking, HTN, DM, HLD, Family Hx
Differential Diagnosis
Investigations
- •ECG: ST elevation/depression, T wave inversion (ACS), S1Q3T3 (PE), Diffuse ST elevation (Pericarditis)
- •Labs: Troponin (serial), D-dimer (low risk PE), CBC, CMP, Lipase
- •Imaging: CXR (Widened mediastinum, PTX, Pneumonia), CT Angio (PE, Dissection)
Management
- 1.1. MONA-B for ACS suspected (Morphine, Oxygen, Nitrates, Aspirin, Beta-blocker)
- 2.2. Anticoagulation if PE confirmed (Heparin/DOAC)
- 3.3. GI Cocktail (Maalox/Lidocaine) helps distinguish GERD (caution: can soothe MI pain too)
- 4.4. NSAIDs/Colchicine for Pericarditis
- 5.5. Urgent Surgery/Consult for Dissection
Monitoring
Continuous Cardiac Monitoring (Telemetry) • Serial Troponins/ECGs • Vital signs (BP asymmetry in dissection)
History Taking
- •Duration: <48h (Viral) vs Prolonged (TB, Endocarditis, Malignancy)
- •Pattern: Continuous vs Intermittent vs Tertian/Quartan (Malaria)
- •Associated: Cough/SOB (Pneumonia), Dysuria (UTI), Rash, Sick contacts
- •Travel: Malaria, Dengue, Typhoid
- •Immunocompromised? HIV, Chemo, Transplant
Differential Diagnosis
Investigations
- •Initial: CBC, CMP, UA, Blood cultures x2 (before antibiotics), CXR
- •If prolonged: ESR/CRP, HIV, Hepatitis panel, PPD/IGRA, CT Chest/Abdomen
- •Special: Echocardiogram (Endocarditis), Lumbar Puncture (Meningitis)
Management
- 1.1. Sepsis Protocol: IV fluids, Broad-spectrum antibiotics (Vanc + Zosyn)
- 2.2. Source Control: Drain abscess, Remove infected catheter
- 3.3. Antipyretics: Acetaminophen 1g q6h, Ibuprofen 600mg q6h
- 4.4. Fever of Unknown Origin (FUO): >3 weeks, no diagnosis after 1 week workup → ID consult
- 5.5. Neutropenic Fever (ANC<500): MEDICAL EMERGENCY → Cefepime 2g q8h
Monitoring
Response to empiric antibiotics • Development of septic shock (Hypotension, Organ dysfunction)
History Taking
- •Unilateral vs Bilateral (Unilateral = DVT/Cellulitis, Bilateral = Systemic)
- •Onset: Acute (DVT) vs Chronic (CHF, Venous insufficiency)
- •Pitting vs Non-pitting (Lymphedema, Myxedema)
- •Associated: Dyspnea (CHF), Proteinuria (Nephrotic), Ascites (Cirrhosis)
- •Medications: CCB (Amlodipine), NSAIDs, Steroids
Differential Diagnosis
Investigations
- •Labs: BNP (CHF), Albumin, Creatinine, UA (Proteinuria), LFTs
- •Imaging: Doppler Ultrasound (DVT), Echocardiogram (Assess EF)
- •Consider: Liver ultrasound (Cirrhosis, ascites)
Management
- 1.1. CHF: Diuresis (Furosemide 40mg daily), Fluid/Salt restriction
- 2.2. DVT: Anticoagulation (Rivaroxaban 15mg BID or Enoxaparin)
- 3.3. Nephrotic: Treat underlying (ACE-I, Steroids if needed)
- 4.4. Medication-induced: Discontinue/Switch offending agent
- 5.5. Compression stockings for Venous insufficiency
Monitoring
Daily weights • Jugular venous distension (JVD) • Urine output
History Taking
- •Location: RUQ (Biliary/Hepatic), RLQ (Appy/Gyn), LLQ (Diverticulitis), Epigastric (PUD/Pancreatitis)
- •Migration? (Periumbilical to RLQ = Appendicitis)
- •Radiation: Back (Pancreatitis/Aorta), Scapula (Cholecystitis), Groin (Renal Colic)
- •Associated: Nausea/Vomiting, Fever, Change in bowel habits, Hematochezia/Melena
Differential Diagnosis
Investigations
- •Labs: CBC, CMP (LFTs), Lipase, UA, Beta-hCG (Females)
- •Imaging:
- • - RUQ Ultrasound (Gallbladder/Liver)
- • - CT Abdomen/Pelvis (Appendicitis, Diverticulitis, Obstruction)
- • - X-ray (Free air/Obstruction - low sensitivity)
Management
- 1.1. NPO, IV Fluids
- 2.2. Pain Control (IV Morphine/Fentanyl - does not mask peritoneal signs)
- 3.3. Antiemetics (Zofran)
- 4.4. Antibiotics if infection suspected (Zosyn/Flagyl+Cipro)
- 5.5. Surgical Consult for 'Acute Abdomen' (Rigid, guarding, rebound)
Monitoring
Serial abdominal exams (Peritonitis?) • Hemodynamics (Sepsis/Bleed) • Urine output
History Taking
- •Onset: Sudden 'Thunderclap' (SAH) vs Gradual
- •Features: Unilateral/Pulsating (Migraine), Band-like (Tension), Periorbital/Lacrimation (Cluster)
- •Red Flags (SNOOP): Systemic signs (fever), Neoplasm history, Onset sudden, Older age (>50 new onset), Pattern change/Papilledema/Pregnancy
Differential Diagnosis
Investigations
- •Physical: Neuro exam, Fundoscopy (Papilledema), Temporal artery palpation
- •Labs: ESR/CRP (Temporal Arteritis)
- •Imaging: CT Head non-contrast (Acute blood), MRI Brain (Tumor, Posterior fossa)
- •Procedures: Lumbar Puncture (Meningitis, SAH if CT negative)
Management
- 1.1. Migraine Cocktail: Fluids + NSAID (Toradol) + Antiemetic (Reglan/Compazine) + Diphenhydramine
- 2.2. Cluster: 100% Oxygen
- 3.3. Tension: NSAIDs, Acetaminophen, Caffeine
- 4.4. Temporal Arteritis: High dose steroids immediately
- 5.5. Meningitis: Empiric Antibiotics + Steroids
Monitoring
Neurologic status • Visual changes • Response to abortive therapy
History Taking
- •Duration: <2 weeks (Acute), 2-4 weeks (Persistent), >4 weeks (Chronic)
- •Volume: Large (Small bowel/Secretory) vs Small frequent (Colonic/Inflammatory)
- •Character: Watery (Viral, Toxin) vs Bloody (Inflammatory - Shigella, E. coli O157)
- •Associated: Fever (Bacterial), Vomiting (Viral, Toxin), Abdominal pain
- •Exposures: Sick contacts, Travel, Antibiotics (C. diff), Raw food
Differential Diagnosis
Investigations
- •Usually clinical diagnosis - Supportive care
- •Stool culture/PCR: If bloody, severe, immunocompromised, or persistent
- •C. diff toxin: If recent antibiotics or hospitalization
- •Stool O&P: If travel to endemic area or >7 days
- •Labs: BMP (Electrolytes, AKI), CBC (Leukocytosis)
Management
- 1.1. Hydration: Oral rehydration solution (ORS) preferred, IV if severe
- 2.2. Diet: BRAT diet (Bananas, Rice, Applesauce, Toast) as tolerated
- 3.3. Antimotility: Loperamide 4mg then 2mg after each stool (Avoid if bloody/high fever)
- 4.4. Antibiotics: Usually NOT needed unless:
- 5. - C. diff: Vancomycin 125mg QID or Fidaxomicin
- 6. - Traveler's diarrhea: Azithromycin 1g single dose or Cipro 500mg BID x3d
- 7. - Shigella/Campylobacter (severe): Azithromycin
- 8.5. Probiotics may reduce duration
Monitoring
Hydration status (Vitals, Urine output, Skin turgor) • Electrolytes • Development of HUS (if E. coli O157 - Do NOT give antibiotics)
History Taking
- •Definition: <3 BM/week or straining/hard stools >25% of time
- •Onset: Acute (Obstruction, Ileus) vs Chronic (Functional, IBS-C)
- •Red flags: Weight loss, Blood in stool, Family history of colon cancer, Age >50 new onset
- •Associated: Abdominal pain, Bloating, Nausea
- •Medications: Opioids, Anticholinergics, Iron, Calcium channel blockers
Differential Diagnosis
Investigations
- •If red flags: Colonoscopy (Rule out cancer)
- •Labs: TSH, Calcium, Glucose
- •Abdominal X-ray: If obstruction suspected (Dilated loops, Air-fluid levels)
- •Anorectal manometry: If dyssynergic defecation suspected
- •Colonic transit study: If slow transit suspected
Management
- 1.1. Lifestyle: Increase fiber (25-35g/day), Fluids (2L/day), Exercise
- 2.2. Bulk-forming: Psyllium (Metamucil) 1 tsp TID with water
- 3.3. Osmotic: Polyethylene glycol (MiraLAX) 17g daily, Lactulose 15-30ml daily
- 4.4. Stimulant: Senna 2 tabs QHS, Bisacodyl 10mg (Use short-term)
- 5.5. Opioid-induced: Peripheral opioid antagonist (Methylnaltrexone), Scheduled laxatives
- 6.6. Refractory: Biofeedback therapy, Rarely surgery
Monitoring
Bowel movement frequency • Complications: Fecal impaction, Hemorrhoids • Response to treatment
History Taking
- •Timing: Acute (Hepatitis, Biliary obstruction) vs Chronic (Cirrhosis)
- •Associated: Dark urine (Conjugated bili), Clay stools (Biliary obstruction), Pruritus (Cholestasis)
- •RUQ pain? (Choledocholithiasis, Cholangitis)
- •Risk factors: Alcohol, Drugs (Acetaminophen), Transfusions, IVDU, Travel
- •Family history: Gilbert's syndrome, Hemolytic anemias
Differential Diagnosis
Investigations
- •Labs: Total/Direct bilirubin, AST/ALT, Alkaline phosphatase, Albumin, PT/INR
- •Pattern: Hepatocellular (AST/ALT >> ALP) vs Cholestatic (ALP >> AST/ALT)
- •Viral serologies: Hep A IgM, HBsAg, Anti-HCV, Consider Hep E
- •Ultrasound RUQ: Dilated ducts (Obstruction), Gallstones, Liver texture
- •MRCP or ERCP: If biliary obstruction
- •Hemolysis workup: CBC, Retic count, Haptoglobin, Coombs test
Management
- 1.1. Choledocholithiasis: ERCP with stone extraction + Sphincterotomy
- 2.2. Cholangitis (Charcot's triad: Fever, Jaundice, RUQ pain): Broad-spectrum antibiotics + URGENT ERCP
- 3.3. Viral Hepatitis A/E: Supportive care (Usually resolves)
- 4.4. Hepatitis B/C: Antiviral therapy (Tenofovir, Entecavir for B; DAAs for C)
- 5.5. Acetaminophen toxicity: N-acetylcysteine (NAC)
- 6.6. Alcoholic hepatitis: Prednisolone 40mg daily (if severe), Abstinence
- 7.7. Pruritus: Cholestyramine 4g BID-QID
Monitoring
Coagulopathy (PT/INR - Synthetic function) • Encephalopathy • Liver enzymes trend
History Taking
- •Timing: Painless (Malignancy, Glomerulonephritis) vs Painful (Stones, UTI)
- •Initial vs Terminal vs Throughout (Bladder origin = Throughout)
- •Associated: Dysuria (UTI), Flank pain (Stone, Pyelonephritis), Weight loss (Cancer)
- •Gross vs Microscopic (>3 RBC/hpf)
- •Risk factors: Smoking (Bladder cancer), Recent URI (Post-infectious GN)
Differential Diagnosis
Investigations
- •UA with Microscopy: RBC casts (Glomerular), WBCs/Bacteria (Infection), Dysmorphic RBCs
- •Urine culture
- •Labs: Creatinine, BUN, CBC, PT/INR (if on anticoagulation)
- •Imaging: CT Urogram (Stones, Masses), Renal ultrasound
- •Cystoscopy: If >35yo, smoking, or risk factors for bladder cancer
- •If glomerular: Complement levels, ANA, ANCA, Anti-GBM
Management
- 1.1. UTI: Antibiotics (Nitrofurantoin, Bactrim)
- 2.2. Kidney stone: Hydration, NSAIDs, Tamsulosin (if <10mm), Urology if large or obstructing
- 3.3. Glomerulonephritis: Nephrology referral, Immunosuppression (Steroids +/- Cyclophosphamide)
- 4.4. Bladder cancer: Transurethral resection (TURBT), Intravesical chemo/BCG
- 5.5. Anticoagulation: Continue if therapeutic, Investigate cause of bleeding
Monitoring
Renal function • Persistence of hematuria • Blood pressure (Glomerular disease)
Created by Safana Abdullah
For educational purposes only. Always consult a medical professional for diagnosis and treatment.